These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Using "number needed to treat" to interpret treatment effect]. Ke DS Acta Neurol Taiwan; 2006 Jun; 15(2):120-6. PubMed ID: 16871900 [TBL] [Abstract][Full Text] [Related]
4. Communicating the benefits and harms of treatments. Akobeng AK Arch Dis Child; 2008 Aug; 93(8):710-3. PubMed ID: 18456681 [TBL] [Abstract][Full Text] [Related]
5. Measures of association in clinical trials: definition and interpretation. Carneiro AV Rev Port Cardiol; 2003 Nov; 22(11):1393-401. PubMed ID: 14768494 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based dermatology: number needed to treat and its relation to other risk measures. Manriquez JJ; Villouta MF; Williams HC J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615 [TBL] [Abstract][Full Text] [Related]
7. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies. Manchikanti L; Datta S; Smith HS; Hirsch JA Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009 [TBL] [Abstract][Full Text] [Related]
8. [Risk and prevention in cardiovascular diseases]. Gulácsi L; Edes I; Hajdú E; Tóthfalusi L Orv Hetil; 2004 Dec; 145(50):2515-21. PubMed ID: 15662751 [TBL] [Abstract][Full Text] [Related]
11. Understanding measures of treatment effect in clinical trials. Akobeng AK Arch Dis Child; 2005 Jan; 90(1):54-6. PubMed ID: 15613512 [TBL] [Abstract][Full Text] [Related]
12. Interpretation of absolute measures of disease risk in comparative research. Replogle WH; Johnson WD Fam Med; 2007 Jun; 39(6):432-5. PubMed ID: 17549653 [TBL] [Abstract][Full Text] [Related]
13. Relative vs. absolute measures of benefit and risk: what's the difference? Citrome L Acta Psychiatr Scand; 2010 Feb; 121(2):94-102. PubMed ID: 19694632 [TBL] [Abstract][Full Text] [Related]
14. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Rücker G; Schwarzer G; Carpenter J; Olkin I Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: when and how. Imperiale TF Hepatology; 1999 Jun; 29(6 Suppl):26S-31S. PubMed ID: 10386080 [TBL] [Abstract][Full Text] [Related]
16. [Concepts important in the interpretation of therapeutic studies. Absolute risk reduction (ARR), relative risk reduction (RRR), number needed to treat (NNT)]. Steurer J Praxis (Bern 1994); 1997 Apr; 86(15):614. PubMed ID: 9213913 [No Abstract] [Full Text] [Related]
17. What is evidence-based medicine and why should I care? Hess DR Respir Care; 2004 Jul; 49(7):730-41. PubMed ID: 15222906 [TBL] [Abstract][Full Text] [Related]